Dissemination & Implementation Core

传播

• 批准号: 10268737
• 负责人: Lisa A. Marsch
• 金额: $ 34.34万
• 依托单位: DARTMOUTH COLLEGE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-08-15 至 2026-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10268737
• 关键词: Adoption; Awareness; Caring; Case Study; Charge; Clinical; Community Practice; Consensus; Data; Dissemination and Implementation; Doctor of Philosophy; Education; Educational workshop; Ethics; Evidence based treatment; Fostering; Funding; Goals; Grant; International; Knowledge; Measurement; Mental Health; Mentors; Mentorship; Methods; National Institute of Drug Abuse; Paper; Population; Population Heterogeneity; Process; Public Health; Publications; Publishing; Research; Research Methodology; Research Personnel; Research Support; Resources; Science; Scientific Advances and Accomplishments; Services; Specific qualifier value; Students; Substance Use Disorder; Technology; Therapeutic Human Experimentation; Therapeutic Uses; Training; Training Programs; Training Support; Training and Education; Translations; Underrepresented Minority; Underrepresented Populations; Work; adaptive intervention; base; care systems; clinical implementation; community college; cost; digital; digital health; digital treatment; dissemination strategy; dual diagnosis; effective therapy; implementation research; implementation science; improved; knowledge base; next generation; physical conditioning; pre-doctoral; scale up; skills; social media; substance use treatment; symposium; therapy development; web site

DISSEMINATION AND IMPLEMENTATION CORE PROJECT SUMMARY Digital therapeutics have demonstrated potential to meet service needs and accelerate translation of science to practice. The charge of the Dissemination and Implementation (D&I) Core is to provide education, training, resources, and scientific guidance to advance implementation science and practice for digital therapeutics for SUDs and CODs. Over the past nine years, the D&I Core has supported activities to promote awareness about the science of digital therapeutics for SUDs and CODs through traditional and digital dissemination channels and developed resources to support application of implementation science in digital therapeutic research. Core affiliates have advanced a conceptual understanding of how implementation science can be applied to digital therapeutic research and contributed to the knowledge base of facilitators and barriers to implementation of digital therapeutics for SUDs across a range of populations and settings. In this renewal, the Core will continue to promote awareness about the science of digital therapeutics (Aim 1) through education, mentorship, and expansion of the CTBH digital platform features to promote cumulative knowledge about clinical evidence for digital therapeutics for SUDs and CODs. As new activities, D&I will work with the Center’s Stakeholder Advisory Board to identify the stakeholder information priorities to inform targeted dissemination strategies and will add a feature to the CTBH website to advance cumulative knowledge about digital therapeutic implementation research. The D&I Core will support adoption and implementation of digital therapeutics (Aim 2) through expanding and refining resources to promote application of implementation science in digital therapeutic research, including implementation case studies and a common implementation measurement framework. New in this renewal, the Core will conduct activities to systematically specify strategies that accelerate implementation of digital therapeutics and offer tutorials to foster actionable skills for digital therapeutic implementation research. To support new Center priorities, the Core will also engage affiliates with active later stage digital health projects to include common clinical and implementation metrics to inform methods for scaling of digital therapeutics, contribute training and methods for use of digital therapeutic usage data and other digital assessment in studies to elucidate implementation mechanisms of action and inform adaptive interventions, promote scientific understanding of determinants and strategies associated with implementation of transdiagnostic digital treatments, provide training and resources in digital health ethics with regard to access equity and cultural relevance of digital therapeutics, and support training and methods to increase representation of underrepresented populations in digital therapeutic research. These efforts will advance the state of implementation science and practice for digital therapeutics for SUDs and CODs.

传播和执行核心项目摘要 数字治疗已经证明了满足服务需求和加速科学转化为 实践传播和实施中心的职责是提供教育、培训、 资源和科学指导，以推进数字治疗的实施科学和实践， SUD和COD。在过去的九年里，D&I核心支持了一些活动，以提高人们对以下问题的认识： 通过传统和数字传播渠道为SUD和COD提供数字治疗学 并开发资源，以支持数字治疗研究中的实施科学应用。核心 附属机构对如何将实施科学应用于数字化有了概念性的理解， 治疗研究，并有助于促进者的知识基础和实施的障碍， 数字化治疗SUD在一系列人群和设置。在这次更新中，核心将 继续通过教育提高对数字治疗学（目标1）的认识， 指导，并扩展CTBH数字平台功能，以促进有关 SUD和COD数字治疗的临床证据。作为新的活动，D&I将与中心的 利益攸关方咨询委员会确定利益攸关方的信息优先事项，以便有针对性地传播 战略，并将增加一个功能，以CTBH网站，以促进积累知识的数字 治疗实施研究。D&I核心将支持数字化的采用和实施 治疗（目标2），通过扩大和完善资源，以促进实施的应用 数字治疗研究的科学，包括实施案例研究和共同实施 测量框架。在这次更新中，核心将开展活动，系统地说明 加速实施数字疗法的战略，并提供教程，以培养可操作的技能， 数字治疗实施研究。为了支持中心新的优先事项，核心还将参与 与活跃的后期数字健康项目合作，包括常见的临床和实施指标， 用于数字治疗缩放的通知方法、用于使用数字治疗的贡献训练和方法 研究中的使用数据和其他数字评估，以阐明行动的执行机制， 知情的适应性干预措施，促进科学地了解与环境有关的决定因素和战略， 实施跨诊断数字治疗，提供数字健康伦理方面的培训和资源， 关注数字治疗的获取公平性和文化相关性，并支持培训和方法， 增加数字治疗研究中代表性不足的人群的代表性。这些努力将 推进SUD和COD数字治疗的实施科学和实践。